Pfizer's Pristiq Phase IV trial shows low potential for sexual dysfunction in MDD patients

Pfizer has reported positive results from its Phase IV clinical trial of Pristiq (desvenlafaxine) in adult patients with major depressive disorder (MDD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news